Pandemic 2009 H1N1 influenza in patients with hematopoietic stem cell transplantation and hematologic malignancy: Single center experience

Oncology

Volumn 79, Issue 5-6, 2011, Pages 409-414

  Tekgündüz, Emre ^a   Yüksel, Meltem Kurt ^a   Erbay, Çiǧdem ^a   Aribaş, Bilgin ^a   Özdilekcan, Çiǧdem ^a   Arslan, Hülya ^a   Koçubaba, Şerife ^a   Demiriz, Itir ^a   Tetik, Ayşegül ^a   Arda, Kemal ^a   Altuntaş, Fevzi ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Hematological malignancy; Hematopoietic stem cell transplantation; Immunocompromised patients; Oseltamivir; Pandemic 2009 H1N1 influenza

Indexed keywords

ACICLOVIR; CYCLOSPORIN; FLUCONAZOLE; LEVOFLOXACIN; METHOTREXATE; METHYLPREDNISOLONE; OSELTAMIVIR; SULFAMETHOXAZOLE; TRIMETHOPRIM;

2009 H1N1 INFLUENZA; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIVIRAL THERAPY; APLASTIC ANEMIA; ARTICLE; ASSISTED VENTILATION; CANCER PATIENT; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; COUGHING; DIARRHEA; DISEASE SURVEILLANCE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; INFECTION RISK; INTENSIVE CARE; MALE; MULTIPLE MYELOMA; MYALGIA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SORE THROAT; SURVIVAL TIME; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 79953172641     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320789     Document Type: Article

References (11)

1. Centers for Disease Control and Prevention: 2009 H1N1 flu: international situation update. www.cdc.gov/h1n1flu/updates/international(accessed March 4, 2010).
2. Echevarria-Zuna S, Mejia-Aranguere JM, Mar-Obeso AJ, et al: Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis. Lancet 2009; 374: 2072-2079.
3. Hudges WT, Armstrong D, Bodey GP, et al: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34: 730-751. (Pubitemid 34194843)
4. Walsh TJ, Anaissie EJ, Denning DW, et al: Treatment of aspergillosis: clinical practice guidelines of Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 337-360.
5. World Health Organization: CDC protocol of real time RT-PCR for influenza A(H1N1). 2009. www.who.int/csr/resources/publications/swinef lu/CDCRealtimeRTPCR-SwineH1Assay-2009-20090430.pdf (accessed October 25, 2010).
6. Lapinsky SE: H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med 2010; 38: 1-6.
7. Regelman-Sidil G, Kamboj M, Huang CK: Pandemic H1N1 influenza infection in cancer patients. Ann Meet Infect Dis Soc America, Philadelphia, 2009.
8. Kunisaki KM, Janoff EN: Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009; 9: 493-504.
9. Casper C, Englund J, Boeckh M: How we treat influenza in patients with hematolo gical malignancies. Blood 2010; 115: 1331-1342.
10. Nichols WG, Guthrie KA, Corey L, Boeckh M: Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 1300-1306. (Pubitemid 39458515)
11. European Blood and Marrow Transplantation Infectious Disease Working Party: A/ H1N1 2009-2010 survey. www.ebmt.org/5WorkingParties/IDWP/wparties-id. html (accessed March 5, 2010).